Cyanotech (OTCMKTS:CYAN) Issues Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) announced its earnings results on Tuesday. The biotechnology company reported $0.12 EPS for the quarter, Zacks reports. The firm had revenue of $7.96 million for the quarter. Cyanotech had a negative net margin of 0.25% and a negative return on equity of 0.86%.

Cyanotech Price Performance

CYAN stock remained flat at $0.54 on Thursday. 49,624 shares of the company were exchanged, compared to its average volume of 2,121. The company has a quick ratio of 0.39, a current ratio of 1.06 and a debt-to-equity ratio of 0.13. Cyanotech has a fifty-two week low of $0.23 and a fifty-two week high of $0.78. The stock has a market capitalization of $4.14 million, a price-to-earnings ratio of -2.16 and a beta of -0.09. The company has a 50 day simple moving average of $0.53 and a two-hundred day simple moving average of $0.46.

Cyanotech Company Profile

Cyanotech Corporation is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products. Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis . Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.